Orexigen diet pill recommended for approval in Europe

LONDON, Dec 19 (Reuters) - A new diet pill from Orexigen Therapeutics Inc has been recommended for approval in Europe, the European Medicines Agency (EMA) said on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.